Description

Retatrutide

Retatrutide (LY3437943) is a synthetic multireceptor agonist peptide currently under study in metabolic and endocrine research. In the scientific literature, retatrutide has been investigated for its interactions with the glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 (GLP-1) receptor pathways. Current research has explored its activity across in vitro and preclinical models, examining receptor signalling, metabolic regulation, and peptide-mediated endocrine pathways. Retatrutide remains an investigational compound in ongoing clinical development.

Manufactured to high analytical standards, this compound is supplied as lyophilised powder for laboratory research and analytical applications.

Purity: ≥99% (HPLC)
Form: Lyophilised Powder
Quantity: 20mg per vial
Molecular Weight: 4731.33 g/mol
CAS: 2381089-83-2
Research: PubMed

Handling and Storage: Store in a cool, dry environment away from direct light. For long-term stability, store refrigerated at 2°C to 8°C. Avoid repeated freeze-thaw cycles and exposure to moisture.

Regulatory Notice: Laboratory Research Use Only. This product is supplied strictly for in vitro laboratory research, analytical, or educational purposes only. Not for human or veterinary use, consumption, therapeutic application, or diagnostic purposes.

Certificates of Analysis and HPLC test results (internal and ISO 17025-accredited third-party) available on request to qualified researchers and clinicians, subject to credential verification. Please include institutional affiliation and intended use with your request.